Supreme Court Continues Temporary Access to Abortion Drug By Mail
The Supreme Court ruled Thursday to continue its temporary stay on Louisiana’s restrictions on mifepristone, a popular abortion drug. This freeze was requested by the plaintiff Danco Laboratories, LLC, the manufacturers of the drug, until the court delivers a concrete ruling.
Subscribe Today
Get daily emails in your inbox
Mifepristone is one of two widely used abortion drugs which Louisiana last fall mandated be dispensed in person. According to Axios, telehealth prescriptions and deliveries make up more than 60 percent of abortions in the U.S. healthcare system.
Offering his dissent, Associate Justice Clarence Thomas rejected the argument for a continued freeze. “Applicants are not entitled to a stay of an adverse court order based on lost profits from their criminal enterprise,” he wrote, citing the Comstock Act of 1873. In a similar dissent, Associate Justice Samuel Alito alleged that the request was “a scheme to undermine our decision in Dobbs v. Jackson.”
This stay is expected to continue until lower courts produce a ruling on the suit.
